Pill Identifier App

JMI D14 (Cytomel 5 mcg (0.005 mg))

Generic Name: liothyronine

Pill imprint JMI D14 has been identified as Cytomel 5 mcg (0.005 mg).

Cytomel is used in the treatment of hypothyroidism, after thyroid removal; tsh suppression; underactive thyroid; myxedema; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Cytomel 5 mcg (0.005 mg) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for JMI D14

Cytomel 5 mcg (0.005 mg) JMI D14 Front
Cytomel 5 mcg (0.005 mg) JMI D14 Back
Cytomel 5 mcg (0.005 mg) JMI D14
Cytomel
Generic Name:
liothyronine
Imprint:
JMI
D14
Strength:
5 mcg (0.005 mg)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
King Pharmaceuticals Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)